PPD, INC. Financial Statements (2024 and earlier)

Company Profile

Business Address 929 NORTH FRONT STREET
WILMINGTON, NC 28401-3331
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

9/30/2021
MRQ
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 768
Cash and cash equivalents 768
Receivables 1,632
Other undisclosed current assets 146
Total current assets: 2,546
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization 20
Operating lease, right-of-use asset 172
Long-term investments and receivables 309
Long-term investments 309
Intangible assets, net (including goodwill) 2,569
Goodwill 1,820
Intangible assets, net (excluding goodwill) 748
Other noncurrent assets 202
Other undisclosed noncurrent assets 476
Total noncurrent assets: 3,748
TOTAL ASSETS: 6,294
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 724
Interest and dividends payable 3
Taxes payable 21
Employee-related liabilities 331
Accounts payable 176
Accrued liabilities 193
Deferred revenue 1,061
Debt 36
Other undisclosed current liabilities 456
Total current liabilities: 2,278
Noncurrent Liabilities
Long-term debt and lease obligation, including: 4,226
Other undisclosed long-term debt and lease obligation 4,089
Liabilities, other than long-term debt 172
Accounts payable and accrued liabilities 19
Deferred income tax liabilities 55
Other liabilities 99
Operating lease, liability 138
Other undisclosed noncurrent liabilities 330
Total noncurrent liabilities: 4,728
Total liabilities: 7,005
Temporary equity, carrying amount 35
Equity
Equity, attributable to parent (747)
Common stock 4
Treasury stock, value (13)
Additional paid in capital 1,820
Accumulated other comprehensive loss (285)
Accumulated deficit (2,272)
Total equity: (747)
TOTAL LIABILITIES AND EQUITY: 6,294

Income Statement (P&L) ($ in millions)

9/30/2021
TTM
12/31/2020
Revenues 4,681
Cost of revenue (3,003)
Cost of goods and services sold (1,961)
Gross profit: 1,679
Operating expenses (1,171)
Operating income: 508
Nonoperating expense (10)
Investment income, nonoperating 53
Other nonoperating expense (63)
Interest and debt expense (94)
Other undisclosed loss from continuing operations before equity method investments, income taxes (217)
Income from continuing operations before equity method investments, income taxes: 188
Loss from equity method investments (8)
Income from continuing operations before income taxes: 179
Income tax expense (19)
Income from continuing operations: 161
Income before gain (loss) on sale of properties:161
Net income: 161
Net loss attributable to noncontrolling interest (7)
Net income attributable to parent: 154
Other undisclosed net loss available to common stockholders, basic (34)
Net income available to common stockholders, diluted: 120

Comprehensive Income ($ in millions)

9/30/2021
TTM
12/31/2020
Net income: 161
Other comprehensive income 14
Comprehensive income: 175
Comprehensive loss, net of tax, attributable to noncontrolling interest (9)
Comprehensive income, net of tax, attributable to parent: 166

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: